Why Long COVID May Change How We Understand Chronic Lyme Disease

Long COVID may change how medicine understands chronic Lyme disease by forcing a broader recognition of persistent symptoms after infection. For decades, patients with fatigue, cognitive dysfunction, pain, and autonomic symptoms following infections have often faced skepticism and limited treatment options.

The emergence of long COVID has renewed scientific interest in what researchers now call infection-associated chronic conditions — illnesses that persist long after the triggering infection appears to have resolved.

What Are Infection-Associated Chronic Conditions?

Researchers increasingly use the term infection-associated chronic conditions (IACCs) to describe illnesses in which symptoms continue long after an infection has ended.

These conditions have been described after many pathogens, including:

• SARS-CoV-2 (Long COVID)
• Epstein-Barr virus
• Enteroviruses
• Borrelia burgdorferi (Lyme disease)
• Giardia and other parasites

Although the pathogens differ, patients often report similar symptoms such as fatigue, cognitive impairment, pain, autonomic dysfunction, and reduced physical capacity.

Why Long COVID Changed the Conversation

Long COVID emerged during a global pandemic, when millions of people experienced infection within a short period of time. Because the timing of infection was clear, persistent symptoms could be recognized more easily than in earlier post-infectious illnesses.

This visibility has made it more difficult to dismiss persistent symptoms as psychological or unrelated to infection.

For patients with chronic Lyme disease, this shift matters. Long COVID has highlighted the possibility that infections may trigger lasting biological changes even after the acute infection resolves.

Why Diagnosis Is Often Difficult

One of the greatest challenges in studying infection-associated chronic conditions is that the triggering infection may no longer be detectable when persistent symptoms develop.

Many infections are mild or unrecognized. By the time fatigue, cognitive problems, or autonomic symptoms appear weeks or months later, routine diagnostic tests may no longer identify the original pathogen.

This diagnostic gap has contributed to decades of uncertainty surrounding illnesses such as ME/CFS, long COVID, and chronic Lyme disease.

When tests are inconclusive, clinicians must rely on clinical history, exposure risk, and longitudinal observation rather than a single definitive biomarker.

Shared Symptoms Across Post-Infectious Illnesses

Patients with long COVID and chronic Lyme disease often report similar symptom patterns, including:

• Fatigue
• Post-exertional worsening
• Brain fog
• Memory or concentration problems
• Dizziness or autonomic instability
• Sleep disturbance
• Pain
• Functional decline despite normal routine testing

These similarities suggest that some biological pathways may overlap across infection-associated chronic illnesses.

Possible Biological Mechanisms

Researchers studying long COVID are exploring several biological mechanisms that may also be relevant to other post-infectious illnesses:

• Immune dysregulation
• Chronic inflammation
• Autonomic nervous system dysfunction
• Coagulation abnormalities
• Reactivation of latent viruses
• Possible persistence of microbial antigens

Not all of these mechanisms will apply equally to every illness. However, studying them systematically may help clarify why some patients develop persistent symptoms after infections such as Lyme disease.

Sex Differences in Post-Infectious Illness

Another striking feature of infection-associated chronic conditions is that they occur more often in women. Long COVID, ME/CFS, and several autoimmune diseases show similar patterns.

Researchers believe this may reflect differences in immune regulation, inflammatory responses, or genetic susceptibility. Understanding these differences may help explain why some individuals are more vulnerable to persistent illness after infection.

Why Patients Have Been Dismissed

When standard diagnostic tests fail to explain persistent symptoms, patients are often told that nothing is wrong. For many individuals with chronic Lyme disease or other post-infectious conditions, this has led to years of uncertainty and frustration.

Long COVID has revealed how common these experiences can be. It has also exposed a major limitation of modern medicine: diagnostic tests do not always capture the biological complexity of chronic illness.

Clinical Perspective

In my clinical practice, patients with persistent symptoms after Lyme disease often describe patterns now widely recognized in long COVID — fatigue, cognitive slowing, fluctuating function, and autonomic symptoms.

Long COVID has not resolved the controversies surrounding chronic Lyme disease, but it has made one thing harder to ignore: persistent symptoms after infection are real and deserve serious scientific study.

The Bottom Line

Long COVID may represent medicine’s best opportunity to understand chronic illness after infection.

If researchers can identify the biological pathways responsible for persistent symptoms after viral infections, those discoveries may also help illuminate the mechanisms behind chronic Lyme disease and other infection-associated chronic conditions.

For patients who have long struggled to have their symptoms recognized, that shift could be transformative.

References

Peluso MJ, Hanson MR, Deeks SG. (2024). Infection-associated chronic conditions: why long COVID is our best chance to untangle Osler’s Web. Science Translational Medicine, 16(773), eado2101.

Komaroff AL, Lipkin WI. (2023). ME/CFS and Long COVID share similar symptoms and biological abnormalities. Frontiers in Medicine, 10, 1187163.

Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A. (1994). Lyme disease: an infectious and postinfectious syndrome. Journal of Rheumatology, 21(3), 454-461.

Bujak DI, Weinstein A, Dornbush RL. (1996). Clinical and neurocognitive features of post-Lyme syndrome. Journal of Rheumatology, 23(8), 1392-1397.

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention